Press
Media Relations
If you are a journalist with a question about Lundbeck or would like to request an interview, please contact Media Relations – and we will get back to you. Please note this service is for journalists and other media professionals only. Please kindly note all other requests to this e-mail will not receive a response.
Contact Media Relations
About Lundbeck
H. Lundbeck A/S (HLUNa / HLUNb, HLUNA DC / HLUNB DC) is a global pharmaceutical company specialized in neurological and psychiatric disorders. For more than 70 years, we have been at the forefront of neuroscience research. We are dedicated to advancing brain health and transforming lives.
Too many people worldwide live with brain diseases – complex conditions often invisible to others that nonetheless take a tremendous toll on individuals, families and societies. We are committed to fighting stigma and discrimination against people living with brain diseases and advocating for broader social acceptance of people with brain health conditions. Every day, we strive for improved treatment and a better life for people living with brain disease.
We have approximately 5,500 employees in more than 50 countries, and our products are available in more than 100 countries. Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 19.9 billion in 2023.
For additional information, we encourage you to visit our corporate website www.lundbeck.com/global and connect with us via LinkedIn.
Facts about Lundbeck
70 years
In the forefront of neuroscience research
100+
Countries of operation around the world
~5,500
Employees worldwide
19.9b DKK
Of revenue generated in 2023